Response to cyclophosphamide and rituximab therapy in idiopathic inflammatory myopathies: A single center experience
Aim of the work: To evaluate the clinical response to cyclophosphamide (CYC), and rituximab (RTX) following CYC regarding muscle power and creatine kinase (CK) level changes, and the ability to manage cardiac and bulbar affection in dermatomyositis (DM) and polymyositis (PM) patients. Patients and m...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-06-01
|
| Series: | Egyptian Rheumatologist |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S111011642100034X |